“The standard became outdated as our knowledge of the harms associated with lower levels of lead exposure developed,” said Dr. Michael Kosnett, a medical toxicologist with the Colorado School of Public Health.
Pediatricians “have been waiting for many decades to have an immunization to prevent RSV, and now we have two, but both have these huge barriers to delivery right now,” said Dr. Sean O’Leary, a pediatric infectious-disease specialist at the University of Colorado Anschutz Medical Campus who researches barriers to vaccination.
“This is a tragedy in its own right and is likely to expand racial health inequalities connected to COVID,” Wendy Netter Epstein, a professor at DePaul University College of Law, and Daniel Goldberg, a public health ethicist at the Center for Bioethics and Humanities at the University of Colorado Anschutz Medical Campus, argue in our opinion pages. “It will also have broader impacts on the community and the economy as COVID will spread, workforce shortages will continue and burdens of long COVID will increase.”
Op-ed coauthored by Daniel Goldberg is an associate professor in the Center for Bioethics and Humanities at the University of Colorado Anschutz Medical Campus.
Op-ed from Jay Lemery, professor of emergency medicine at the University of Colorado School of Medicine, co-director of its Climate & Health Program and a member of the National Academy of Medicine.
Other researchers are eager to play that role. At USC, a team led by Dr. Heinz-Josef Lenz will be testing baricitinib and remdesivir in a clinical trial with 59 COVID0-19 patients, while another group at the University of Colorado’s Anschutz Medical Campus turned on a dime to design a clinical trial of baricitinib in 80 COVID-19 patients. “As a general principle, reproducibility in science is a central pillar,” said Dr. Joaquin Espinosa, who is leading the work in Colorado.
Dr. Sean O’Leary, a professor at the University of Colorado School of Medicine and a member on the infectious diseases committee for the American Academy of Pediatrics, understands the over-precaution new parents and even pediatricians are practicing because “we haven’t got a lot of research with newborns” and the coronavirus.
Dr. Saketh Guntupalli, a gynecological oncologist at the University of Colorado, raised the stakes. “If you exclude 50% of people from anything, think about how much you’ve lost,” he said. “You might lose the next person who's going find a cure for cancer.”
